Article Information
History
- December 6, 2022.
Article Versions
- Version 1 (November 30, 2022 - 15:39).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Hao Kang1,#,
- Hongjian Sun2,3,#,
- Yang Yang2,3,
- Minglei Shu3,
- Yunbo Wei4,
- Yu Zhang4,
- Di Yu2,5,*,† and
- Yong Tao1,*,†
- 1Department of Ophthalmology, Beijing Chaoyang Hospital, Capital Medical University
- 2Frazer Institute, Faculty of Medicine, The University of Queensland, Brisbane, QLD, Australia
- 3Shandong Artificial Intelligence Institute, Qilu University of Technology (Shandong Academy of Sciences), Jinan, China
- 4School of Pharmaceutical Sciences, Laboratory of Immunology for Environment and Health, Shandong Analysis and Test Center, Qilu University of Technology (Shandong Academy of Sciences), Jinan, China
- 5Ian Frazer Centre for Children’s Immunotherapy Research, Children’s Health Research Centre, Faculty of Medicine, The University of Queensland, Brisbane QLD, Australia
- ↵†Correspondence: Prof. Yong Tao, Department of Ophthalmology, Beijing Chaoyang Hospital, Capital Medical University; No. 8, South Road of Worker’s Stadium, Chaoyang District, Beijing 100020, China. Phone: +86-10-85231718. Fax: +86-10-85231405. E-mail: taoyong{at}bjcyh.com, Prof. Di Yu, Frazer Institute, Faculty of Medicine, The University of Queensland. Translational Research Institute (TRI), 37 Kent Street, Woolloongabba, QLD 4102, Australia. Phone: +61-07-34436954. E-mail: di.yu{at}uq.edu.au